No Detail Found!

Correlation of Proline, Kynurenic Acid and Glutamate Levels with Cognitive Function: Insights from Digit Span, TMT and RAVLT in Schizophrenia

Author(s)
Mutiara Anissa Department of Biomedical Sciences, Faculty of Medicine, Universitas Andalas, Padang, West Sumatra 25175, Indonesia
Afriwardi Department of Physiology, Faculty of Medicine, Universitas Andalas, Padang, West Sumatra 25175, Indonesia
Yaslinda Yaunin Department of Psychiatry, Faculty of Medicine, Universitas Andalas, Padang, West Sumatra 25175, Indonesia
Rauza Sukma Rita Department of Biochemistry, Faculty of Medicine, Universitas Andalas, Padang, West Sumatra 25175, Indonesia
Abstract
Background and Objective: Schizophrenia s a severe and chronic mental disorder which are characterized by delusions, hallucinations, disorganized speech, catatonic behavior, negative symptoms and cognitive symptoms. Several gene polymorphisms and neurotransmitters have been linked to schizophrenia. This study assessed the correlation between proline level, Kynurenic Acid (KYNA) and glutamate level with cognitive function among schizophrenia patients, contributintgo understanding biochemical factors associated with cognitive impairments. Materials and Methods: The research was a cross-sectional observational analytic study of 99 patients diagnosed with schizophrenia. Schizophrenia was diagnosed by SCID-1 questionnaire and the patient s blood was taken to be analyzed in the Biochemical Laboratory of Medical Faculty Andalas University using Enzyme-Linked Immunosorbent Assay (ELISA) to characterize kynurenic acid level, glutamate level and proline level. Data were analyzed using Spearman Correlation in SPSS 25.0, with significance at p<0.05. Results: There were 99 schizophrenia patients; most of them were male (62.6%), age median 37 years old and not married (50.5%). The Microproline Level medianamong participants was 2.64 pg/mL, the median KYNAlevel was 14.6 nmol/L and the glutamate level was 10.5 ug/mL. Cognitive function was assessed by Rey Auditory Verbal Learning Test (RAVLT), Digit Span Test and Trail Making Test (TMT) with a score median of 4/5/5/5 (Trial 1/2/3/Recall), 6/2 (forward/backward), 68/37 sec (TMT A/B), respectively. Spearman Correlation showed that microproline has a negative correlation with RAVLT Trial 1 (r=-0.221, p=0.014), Digit Span Backward (r=-0.181,p=0.03T6MT),A (r=0.204, p =0.021) and TMT B (r =0.185, p = 0.034). In contrast, other neurotransmitters do not correlate with any cognitive tests. Conclusion: Proline may play a role in the pathophysiology of cognitive deficits in schizophrenia, highlighting its potential as a target for therapeutic interventions.
Publication Details
Page(s) 308-317
Published Journal: Pakistan Journal of Biological Sciences, Volume: 28, Issue: 5, Year: 2025

Request the full text from PASTIC

Keywords
Proline, Schizophrenia, Cognitive function, kynurenic acid, glutamate
References
Orsolini U.,Volpe U. .2022 .. , : .
. .treatment aspects. J. Clin. Med, 11 : .
. .. , : .
Peritogiannis V.,Ninou A.,Samakouri M. .2022 .. , : .
. .understanding and management. Healthcare, 10 : .
. .. , : .
. .of schizophrenia and its management over 8-years period. , : .
. .using real-world data in Spain. BMC Psychiatry, 20 : .
Stockings E. .2018 .Global epidemiology and burden of. , : .
study .2016 .Schizophr. , 44 : 1195-1203.
Wulandari A.,All A. .2023 .. , : .
Arianti D .2024 .. Sanusi, : .
Cendikia Mandira . .. , 3 : 125-133.
.2017 .Theranostic biomarkers for schizophrenia. , : .
Int. J. Mol. Sci. . .. , 18 : .
Damanik R,Husada M.S. .2020 .. , : .
. .of gene polymorphism interferon gamma+874 A/T and. , : .
Med Maced. J. . .. , 8 : 70-75.
ARA. Balagtas T.,Poprawski T. .2022 .. , : .
Cureus ,AV ,Stepanov V.A.,Marusin A.V.,Kharkov V.N. . .. , 14 : .
Vagaitseva K.V. .2017 .. , : .
Genet Russ. J.,Lin P,Sun J.,Lou X.,Li D.,Shi Y. .2022 .. , 53 : 139-146.
. .clinical tests for schizophrenia. Gen. Psychiatry, 35 : .
. .. , : .
. Karimian S.S. .2018 .. T. Akbari, : .
. .in the Iranian patients. J. Hum. Genet. Genomics, 2 : .
. .. , : .
. Qin X,J.ChenandT.Zhou X .2020 .. , 22 : 11.
. .and schizophrenia. Acta Biochim. Biophys, 52 : 1181-1190.
. Guo X,Tang P.,Yang C.,Li R. .2018 .. , : .
Dis . .. , 33 : 89-97.
Gordon J.A.,Gogos J.A. .2016 .. , : .
J.ASN..M. . .VVerhooevern-DusifatndJ. mR.Ziankstnok, 2 : 021.
Sacchi S.,Pollegioni L. .2018 .. , : .
. .in a U87 glioblastoma cell line. PLoS ONE, 13 : .
. .. , 0196283 : .
. .Lack of association between proline dehydrogenase. , : .
. .(oxidase) 1 polymorphisms and schizophrenia in a Korean. , : .
Genet population. Psychiatric . .. , 22 : 153-154.
RH. Nadrich .2016 .. , : .
. .schizophrenia and bipolar disorder. Transl. Psychiatry, 6 : .
Wyse .2011 .. , 157 : .
Clelland CL . .. , 26 : 21-172.
CA. Pappas .2011 .Evidence for association of. , : .
outcome. Schizophr. Res. ,Caravaggio F. . .. , 131 : 139-145.
JK. Chung .2017 .. , : .
Kindler J,Boerrigter D. . .. , 43 : 23-777.
Galletly C. .2020 .. , : .
Réus GZ,Scaini G.,Petronilho F. . .. Mol. Psychiatry, 25 : 24-2872.
JP. Oses .2018 .The inhibition of the kynurenine. , : .
Psychiatry ,Abdullahi D.,Tripathi P.T.,Ronaldson P.T. .2018 .. , 81 : 25-63.
Physiol Am. J. Physiol. Cell,Nation D.A,M.D. Sweeney A.,Montagne A. . .. , 315 : 26-C356.
L.M. D'Orazio .2019 .Blood-brain barrier breakdown. , : .
Nat. Med. ,Kruse A.O.,JR. Bustillo A.O. .2022 .. , 25 : 27-276.
. .dysfunction in schizophrenia. Transl. Psychiatry, 12 : .
Kahn RS . .. , : 541398.
DR. Weinberger .2015 .. Nat. Rev. Dis., : .
Primers ,Song J,Viggiano A.,Monda M. .2014 .. , 67 : .
McCutcheon RA,Howes O.D. .2020 .ameta-analysis. Neuropsychobiology, 70 : 133-141.
Huang H.,Duan J. .2022 .symptoms and treatment. World Psychiatry, 19 : 15-33.
Madeira C,Alheira F.V. . .biomarkers for schizophrenia. Med, 2 : 32-416.
F.M. Tannos .2018 .Blood levels of glutamate and. , : .
Front. Psychiatry ,AS. Boyko S.A,Fedorenko O.Y.,Krotenko N.M. .2018 .. , 00713 : .
Semke A.V.,Bokhan N.A. .2014 .. , : .
J.D. .2019 .. , 10 : 80-85.
Bauminger ,Gaisler-Salomon .2022 .. , 24 : 35-642.
Mol schizophrenIinta..J.,Nakazawa K.,Jeevakumar V.,Nakao K. .2017 .. , 23 : .
. .leading to schizophrenia. npj Schizophr, 3 : .
Elmslie D.,Yoshikami D. .1985 .. , : 37.
Hilmas C,EF.R. Pereira M.,Alkondon A . .inthe frog spinal cord. Brain Res., 330 : 38-272.
Schwarcz R. .2001 .. , : .
. .metabolite kynurenic acid inhibits a7 nicotinic receptor. , : .
. .activity and increases non-a7 nicotinic receptor expression:. , : .
Neurosci Physiopathological implications.J.,Dobelis P,Cooper D.C. .2012 .. , 21 : 39-7473.
. .modulation of nicotinic acetylcholine alpha-7 receptor. , : .
. .. PLoS ONE, 7 : .
Perkins T.W.,Stone T.W. .1982 .. , 0041108 : .
Res acid. Brain,Konradsson-Geuken A,Wu H.Q. . .. , 247 : 41-187.
.2010 .. and A Campbell er a/, : .
Neuroscience ,Carpenedo R,Pittaluga A.,Cozzi S.,Attucci A . .. , 169 : 1848-1859.
Raiteri M.,Moroni F. .2001 .. , : .
Beggiato S.,Tanganelli K.,Fuxe T.,Antonelli T. . .. , 13 : 43-2147.
Ferraro and L. .2014 .Endogenous kynurenic acid regulates. , : .
Neuropharmacology . .. , 82 : 11-18.
Bruno R. Schwarczand J.P. .2009 .Astrocyte-derived kynurenic. , : .
Neurosci release. Eur.J.,Fazio F,Lionetto L,Curto M. . .. , 29 : 45-538.
M. Cavallari .2016 .. Xanthurenic acid activates mGlu2/3, : .
Chiappelli J,F.M. Notarangelo J . .markerfor schizophrenia. Sci.Rep, 5 : .
Kochunov and P. .2014 .Stress-induced increase in. , : .
Sellgren CM,Gracias J.,Jungholm O. . .. , 71 : 47-768.
.2019 .Peripheral and central levels of. , : .
. .healthy controls. , 9 : .
Rodriguez-Jimenez R . .. , : 48.
Santabarbara J.,A.l. Aparicio etal J. .2019 .. , : .
Schizophr. Res. ,Chess ,Alling T.E.,Bucci D.J. .2007 .MK. , 211 : 49-92.
. .working memory deficits. Schizophr. Bull, 33 : 797-804.
0

Citations

0

Downloads

110

Views